mmwr
march
total
confirm
case
novel
coronaviru
infect
report
world
health
organ
death
ill
onset
occur
april
februari
date
case
report
unit
state
three
confirm
case
novel
coronaviru
infect
identifi
unit
kingdom
uk
part
cluster
within
one
famili
index
patient
cluster
man
age
year
histori
recent
travel
pakistan
saudi
arabia
develop
respiratori
ill
januari
return
uk
januari
hospit
januari
sever
lower
respiratori
tract
diseas
receiv
intens
care
respiratori
specimen
patient
taken
februari
test
posit
influenza
viru
novel
coronaviru
infect
second
patient
adult
male
household
member
underli
medic
condit
becam
ill
februari
contact
index
patient
receiv
intens
treatment
die
sever
respiratori
diseas
patient
underli
ill
might
made
suscept
sever
respiratori
infect
third
patient
adult
femal
develop
respiratori
ill
februari
follow
contact
index
patient
hospit
requir
hospit
recov
februari
index
patient
travel
recent
outsid
uk
base
ongo
investig
cluster
ill
uk
health
protect
agenc
conclud
persontoperson
transmiss
like
occur
uk
within
famili
recent
cluster
provid
first
clear
evid
humantohuman
transmiss
novel
coronaviru
coinfect
novel
coronaviru
anoth
pathogen
influenza
case
mild
ill
associ
novel
coronaviru
infect
light
develop
updat
guidanc
post
center
diseas
control
prevent
coronaviru
websit
http
wwwcdcgovcoronavirusncv
editori
comment
report
followup
news
articl
publish
clinic
infecti
diseas
issu
ago
fact
march
case
death
probabl
cluster
involv
persontoperson
spread
previous
report
howev
cluster
uk
clearcut
possibl
sourc
secondari
case
index
case
cluster
occur
countri
diseas
occur
food
drug
administr
march
us
food
drug
administr
fda
warn
public
azithromycin
zithromax
zmax
caus
abnorm
chang
electr
activ
heart
may
lead
potenti
fatal
irregular
heart
rhythm
patient
particular
risk
develop
condit
includ
known
risk
factor
exist
qt
interv
prolong
low
blood
level
potassium
magnesium
slower
normal
heart
rate
use
certain
drug
treat
abnorm
heart
rhythm
arrhythmia
commun
result
review
studi
medic
research
well
anoth
studi
manufactur
drug
assess
potenti
azithromycin
caus
abnorm
chang
electr
activ
heart
azithromycin
drug
label
updat
strengthen
warn
precaut
section
inform
relat
risk
qt
interv
prolong
torsad
de
point
specif
rare
heart
rhythm
abnorm
inform
also
ad
regard
result
clinic
qt
studi
show
azithromycin
prolong
qt
interv
healthcar
profession
consid
risk
fatal
heart
rhythm
azithromycin
consid
treatment
option
patient
alreadi
risk
cardiovascular
event
fda
note
potenti
risk
qt
prolong
azithromycin
place
appropri
context
choos
antibacteri
drug
altern
drug
macrolid
class
nonmacrolid
fluoroquinolon
also
potenti
qt
prolong
signific
side
effect
consid
choos
antibacteri
drug
fda
releas
statement
may
new
england
journal
medicin
studi
compar
risk
cardiovascular
death
patient
treat
antibacteri
drug
azithromycin
amoxicillin
ciprofloxacin
cipro
levofloxacin
levaquin
antibacteri
drug
studi
report
increas
cardiovascular
death
risk
death
caus
person
treat
cours
azithromycin
zithromax
compar
person
treat
amoxicillin
ciprofloxacin
drug
risk
cardiovascular
death
associ
levofloxacin
treatment
similar
associ
azithromycin
treatment
prepar
editor
march
man
recent
die
rabi
maryland
year
receiv
kidney
transplant
organ
recipi
receiv
organ
donor
die
florida
donor
organ
includ
kidney
heart
liver
transplant
recipi
florida
georgia
illinoi
maryland
donor
enceph
suspect
rabi
diagnosi
rabi
made
recipi
donor
death
investig
found
caus
rabi
organ
donor
unit
state
test
see
infect
would
preclud
transplant
test
conduct
viral
diseas
hepat
human
immunodefici
viru
rabi
suspect
caus
death
accord
center
diseas
control
prevent
rabi
suspect
test
rabi
routin
perform
organ
recipi
receiv
rabi
vaccin
viru
believ
raccoon
strain
exposur
donor
probabl
occur
north
carolina
move
florida
incub
period
year
half
patient
incub
period
rabi
typic
month
may
vari
week
year
transmiss
rabi
organ
tissu
transplant
extrem
rare
four
peopl
texa
die
die
germani
rabi
cluster
rabi
contract
singl
donor
tissu
least
case
worldwid
acquir
corneal
transplant
mmwr
may
outbreak
shigellosi
associ
privat
bridg
club
investig
investig
document
first
known
transmiss
shigella
sonnei
decreas
suscept
azithromycin
unit
state
case
defin
ill
clinic
compat
shigellosi
patient
sonnei
isol
stool
person
epidemiolog
link
bridg
club
may
stool
specimen
collect
worker
handl
food
worker
member
diarrhea
thirtynin
case
identifi
among
club
member
diarrhea
among
club
worker
worker
includ
one
handl
food
report
symptom
averag
age
affect
person
year
rang
year
femal
among
symptom
durat
ill
averag
day
rang
day
common
symptom
includ
diarrhea
patient
abdomin
cramp
fever
thirtyon
person
sought
medic
care
hospit
specif
exposur
implic
sourc
outbreak
among
case
cultureconfirm
isol
underw
pulsedfield
gel
electrophoresi
yield
indistinguish
pattern
four
isol
submit
center
diseas
control
prevent
nation
antimicrobi
resist
monitor
system
narm
display
resist
streptomycin
sulfisoxazol
tetracyclin
trimethoprimsulfamethoxazol
unlik
shigella
isol
test
narm
isol
also
show
elev
azithromycin
minimum
inhibitori
concentr
mic
harbor
plasmidencod
macrolid
resist
gene
mpha
although
sporad
case
shigellosi
caus
shigella
strain
increas
azithromycin
mic
occur
first
outbreak
document
unit
state
might
indic
increas
circul
strain
ill
outbreak
tend
sever
howev
affect
popul
much
older
gener
us
popul
although
azithromycin
current
recommend
treatment
infect
caus
multidrugresist
shigella
option
altern
treatment
among
children
infect
primarili
includ
parenter
antimicrobi
medic
guidelin
azithromycin
suscept
test
criteria
interpret
mic
shigella
speci
publish
editori
comment
interest
aspect
report
discuss
first
suscept
ciprofloxacin
specif
mention
agent
commonli
use
adult
azithromycin
assum
shigella
suscept
also
outbreak
demonstr
extrem
infect
shigella
occur
group
adult
preschool
shigella
caus
diseas
number
easili
transmit
handshak
share
peanut
elderli
even
suscept
increas
incid
achlorhydria
